ABOS
Price
$1.39
Change
+$0.03 (+2.21%)
Updated
Sep 3 closing price
Capitalization
82.99M
74 days until earnings call
TCRX
Price
$1.87
Change
+$0.12 (+6.86%)
Updated
Sep 3 closing price
Capitalization
106.12M
62 days until earnings call
Interact to see
Advertisement

ABOS vs TCRX

Header iconABOS vs TCRX Comparison
Open Charts ABOS vs TCRXBanner chart's image
Acumen Pharmaceuticals
Price$1.39
Change+$0.03 (+2.21%)
Volume$137.61K
Capitalization82.99M
TScan Therapeutics
Price$1.87
Change+$0.12 (+6.86%)
Volume$278.61K
Capitalization106.12M
ABOS vs TCRX Comparison Chart in %
Loading...
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABOS vs. TCRX commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABOS is a Hold and TCRX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (ABOS: $1.39 vs. TCRX: $1.87)
Brand notoriety: ABOS and TCRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABOS: 36% vs. TCRX: 110%
Market capitalization -- ABOS: $82.99M vs. TCRX: $106.12M
ABOS [@Biotechnology] is valued at $82.99M. TCRX’s [@Biotechnology] market capitalization is $106.12M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.69B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABOS’s FA Score shows that 0 FA rating(s) are green whileTCRX’s FA Score has 1 green FA rating(s).

  • ABOS’s FA Score: 0 green, 5 red.
  • TCRX’s FA Score: 1 green, 4 red.
According to our system of comparison, TCRX is a better buy in the long-term than ABOS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABOS’s TA Score shows that 4 TA indicator(s) are bullish while TCRX’s TA Score has 6 bullish TA indicator(s).

  • ABOS’s TA Score: 4 bullish, 4 bearish.
  • TCRX’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, TCRX is a better buy in the short-term than ABOS.

Price Growth

ABOS (@Biotechnology) experienced а 0.00% price change this week, while TCRX (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.29%. For the same industry, the average monthly price growth was +15.06%, and the average quarterly price growth was +30.89%.

Reported Earning Dates

ABOS is expected to report earnings on Nov 17, 2025.

TCRX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+0.29% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TCRX($106M) has a higher market cap than ABOS($83M). ABOS YTD gains are higher at: -19.186 vs. TCRX (-42.434). TCRX (-130.55M) and ABOS (-132.35M) have comparable annual earnings (EBITDA) . TCRX has more cash in the bank: 218M vs. ABOS (143M). ABOS has less debt than TCRX: ABOS (30.1M) vs TCRX (96.7M). TCRX has higher revenues than ABOS: TCRX (6.96M) vs ABOS (0).
ABOSTCRXABOS / TCRX
Capitalization83M106M78%
EBITDA-132.35M-130.55M101%
Gain YTD-19.186-42.43445%
P/E RatioN/AN/A-
Revenue06.96M-
Total Cash143M218M66%
Total Debt30.1M96.7M31%
TECHNICAL ANALYSIS
Technical Analysis
ABOSTCRX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
71%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 17 days ago
78%
Bullish Trend 10 days ago
82%
Declines
ODDS (%)
Bearish Trend 7 days ago
88%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 2 days ago
87%
Aroon
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATRRF115.13N/A
N/A
Altarea Paris
BLHWF963.02N/A
N/A
Belimo Holding AG
LKST4.26N/A
N/A
LookSmart Group, Inc.
NICXF0.30N/A
N/A
Nicox S.A.
NTCPF0.96N/A
-0.11%
Northisle Copper and Gold Inc.

ABOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABOS has been loosely correlated with KYTX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ABOS jumps, then KYTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABOS
1D Price
Change %
ABOS100%
+2.21%
KYTX - ABOS
46%
Loosely correlated
+3.62%
CRBU - ABOS
45%
Loosely correlated
+0.53%
GLSI - ABOS
44%
Loosely correlated
+0.61%
BEAM - ABOS
43%
Loosely correlated
+15.02%
CELC - ABOS
43%
Loosely correlated
+1.16%
More

TCRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCRX has been loosely correlated with MGNX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if TCRX jumps, then MGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCRX
1D Price
Change %
TCRX100%
-2.78%
MGNX - TCRX
47%
Loosely correlated
-1.69%
FATE - TCRX
45%
Loosely correlated
-0.96%
ABOS - TCRX
42%
Loosely correlated
N/A
CRBU - TCRX
41%
Loosely correlated
+0.53%
IMNM - TCRX
40%
Loosely correlated
-2.42%
More